IMA Advisory Services’s Medicines Co MDCO Stock Holding History

IMA Advisory Services’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-49,042	Closed	-$1.86M	–	136
2017 Q2	$1.86M	Sell	49,042 -1,719	-3%	-$76.6K	0.9%	34
2017 Q1	$2.48M	Sell	50,761 -42,738	-46%	-$1.95M	1.25%	22
2016 Q4	$3.17M	Sell	93,499 -6,940	-7%	-$246K	1.95%	12
2016 Q3	$3.79M	Buy	100,439 +870	+0.9%	+$32.8K	2.17%	9
2016 Q2	$3.3M	Sell	99,569 -15,845	-14%	-$559K	2.07%	9
2016 Q1	$3.62M	Hold	115,414	–	–	2.1%	10
2015 Q4	$4.18M	Buy	115,414 +2,469	+2%	+$93.3K	2.54%	8
2015 Q3	$4.22M	Sell	112,945 -2,365	-2%	-$83K	2.67%	4
2015 Q2	$3.3M	Buy	115,310 +2,950	+3%	+$82.2K	1.57%	20
2015 Q1	$3.15M	Buy	112,360 +3,720	+3%	+$104K	1.53%	24
2014 Q4	$3.01M	Buy	108,640 +1,280	+1%	+$31.7K	1.55%	19
2014 Q3	$2.4M	Buy	+107,360	New	+$2.73M	1.13%	29

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IMA Advisory Services's MDCO Position: Q3 2017 in Review

IMA Advisory Services sold out of Medicines Co (MDCO) in Q3 2017, closing a stake of 49,042 shares — an estimated $1.86M sold.

IMA Advisory Services first reported a position in MDCO in Q3 2014 and held it in 12 quarters. The position peaked at $4.22M in Q3 2015. 190 funds tracked by Wall St. Rank hold MDCO as of Q3 2017.

IMA Advisory Services reported no remaining Medicines Co position as of Q3 2017 after selling out during the quarter.
IMA Advisory Services sold 49,042 Medicines Co shares in Q3 2017, an estimated $1.86M.
IMA Advisory Services first reported a position in Medicines Co in Q3 2014 and held it in 12 quarters.
IMA Advisory Services's Medicines Co position peaked at $4.22M in Q3 2015.
190 funds tracked by Wall St. Rank held Medicines Co as of Q3 2017.

Based on IMA Advisory Services's 13F filing for Q3 2017, filed 24 Oct 2017.